Families USA Comments on Medicaid 1115 Waivers and 1332 Innovation Waivers - Families USA Skip to Main Content

Families USA Comments on Medicaid 1115 Waivers and 1332 Innovation Waivers

Families USA Comments on Medicaid 1115 Coverage Waivers, by State

National

This letter was sent on Wednesday, May 9, 2018, to Health and Human Services Secretary Azar urging HHS to address concerns about the 1115 waiver process that were raised in a recent Government Accountability Office (GAO) report. The GAO report, published in February,  found that the federal government has failed to require complete and timely evaluations of the waivers from states, and failed to make evaluations public. The letter urges Secretary Azar to halt approvals of Medicaid 1115 waivers that have the effect of limiting eligibility, reducing enrollment, or curtailing program benefits until HHS demonstrates it has the capacity to conduct comprehensive public evaluations of its existing waivers.

The letter was signed by over 70 state and national organizations, including Families USA, the National Health Law Program, the American College of Obstetricians and Gynecologists, the American Diabetes Association, the Children’s Defense Fund, and the Planned Parenthood Federation of America.

Alabama

Arizona

Arkansas

Florida

Indiana

Iowa

Kansas

Kentucky

Maine

Massachusetts

Michigan

Mississippi

Montana

Nebraska

New Hampshire

North Carolina

  • North Carolina Medicaid and NC Health Choice Amended Section 1115 Demonstration waiver – (2018)

Ohio

Tennessee

Utah

Virginia

Wisconsin

1332 Innovation Waivers Comments from Families USA

Tools for Advocates

A waiver is a state request that the Secretary of Health and Human Services waive certain federal health care program requirements, usually in Medicaid (Section 1115 waivers) or the marketplaces (Section 1332). 

Contact Us

Our partners in the states are our best resource. If you learn about a waiver being developed in your state, please let us know. Contact Us